Age-adjusted D-dimer cutoffs can safely rule out deep vein thrombosis (DVT) in many suspected cases, according to the ...

If this kind of company isn't your style, you like companies that generate revenue, and even earn profits, then you may well be interested in IDACORP (NYSE:IDA). Even if this company is fairly valued ...

China: A prospective multicentre cohort study from China suggests that telitacicept, when used alongside standard of care ...

A prospective validation study found that age-adjusted D-dimer thresholds can safely rule out lower extremity DVT for more ...

Rocket Lab Corporation earns a Strong Buy as profitability nears, EPS beats, and revenue accelerates. Click for this updated ...

An institutional perspective on credit portfolios built for durability, probability-weighted outcomes, and cycle resilience.

While SoFi Technologies suffered a snap pullback due to valuation concerns, the severe bearishness opens a contrarian trade ...

While Zeta Global is up big on a possible short squeeze, ZETA stock is flashing a quant signal that points to even more ...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Unfortunately, these high risk investments ...

Is it possible to recover plastic recyclates from previously unused waste streams in order to produce high-quality fibers and ...

Clinical outcomes from routine practice confirm ocrelizumab effectiveness in relapsing MS, with low rates of disability worsening over 4 years.

In 2020, RUSI published papers on the potential threats posed to Western forces by Russian and Chinese combat air ...